SCHEMBL8911435

SCHEMBL8911435

CCOC(=O)CCN(CCC(=O)OCC)c1ccc(C)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.54
POLB P06746 1/20 0.44
RAB9A P51151 1/20 0.44
CYP4F2 P78329 3/20 0.44
CYP4A11 Q02928 3/20 0.44
MAPT P10636 2/20 0.41
GAA P10253 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
ALOX5 P09917 1/20 0.40
LTA4H P09960 2/20 0.40
CNR2 P34972 2/20 0.40
CYP2C19 P33261 1/20 0.39
PPARG P37231 1/20 0.39
CYP1A2 P05177 1/20 0.39
CNR1 P21554 1/20 0.39
ALDH1A1 P00352 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14947362 0.90 SMN1; SMN2 (0.51) SMN1; SMN2POLBRAB9ACYP4F2CYP4A11
SCHEMBL9831771 0.89 SMN1; SMN2 (0.51) SMN1; SMN2POLBRAB9ACYP4F2CYP4A11
SCHEMBL10525189 0.86 SMN1; SMN2 (0.67) SMN1; SMN2POLBCYP4F2CYP4A11ALOX5
SCHEMBL10686678 0.85 PPARG (0.53) SMN1; SMN2RAB9AMAPTGAATSHR
SCHEMBL1120541 0.83 SMN1; SMN2 (0.51) SMN1; SMN2POLBRAB9ACYP4F2CYP4A11
SCHEMBL11854270 0.83 SMN1; SMN2 (0.48) SMN1; SMN2CYP4F2CYP4A11MAPTHSD17B10
SCHEMBL5714050 0.82 CYP4F2 (0.44) SMN1; SMN2POLBCYP4F2CYP4A11MAPT
SCHEMBL9654341 0.81 SMN1; SMN2 (0.52) SMN1; SMN2RAB9ACYP4F2CYP4A11MAPT
SCHEMBL11718440 0.81 SMN1; SMN2 (0.60) SMN1; SMN2POLBCYP4F2CYP4A11GAA
SCHEMBL7516206 0.81 CYP3A4 (0.46) SMN1; SMN2RAB9AMAPTGAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130118570-A1 DYE FOR PHOTOELECTRIC CONVERSION, SEMICONDUCTOR ELECTRODE, PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, AND NOVEL PYRROLINE-BASED COMPOUND NEC CORPORATION (JP) 2013-05-16 US disclosed
US-5625046-A Hydroxyl projecting groups for organic synthesis KING'S COLLEGE LONDON (GB) 1997-04-29 US disclosed
US-5436331-A Etherification with N-aryl-4-alkoxy-1,2,5,6-tetrahydropyidine KINGS COLLEGE LONDON (GB) 1995-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130118570-A1 DYE FOR PHOTOELECTRIC CONVERSION, SEMICONDUCTOR ELECTRODE, PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, AND NOVEL PYRROLINE-BASED COMPOUND SCO2, PYCR1, CRY1 SMN1; SMN2 4148/4885POLB 2241/4885RAB9A 1459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.